Why Transcat, Inc.’s (TRNS) Stock Is Down 5.55%
As of Wednesday, July 29, Transcat, Inc.’s TRNS share price has dipped by 5.55%, which has investors questioning if this is right time to buy.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. The company operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers’ assets; and Compliance, Control, and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers’ test and measurement instrumentation needs, as well as value-added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense, industrial manufacturing, energy and utilities, oil and gas, chemical manufacturing, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.
Commentary & Analysis
Why Transcat, Inc.’s (TRNS) Stock Is Down 6.19%
As of Wednesday, May 27, Transcat, Inc.’s TRNS share price has dipped by 6.19%, which has investors questioning if this is right time to buy.Rosalio Madrigal
What You Need to Know About Transcat, Inc.'s Q1 Earnings
Transcat, Inc.'s fiscal Q1 earnings report was released on Tuesday, May 26. Let's dive in to see if (TRNS) missed or beat analyst's expectations.Michael Rose
Why Transcat, Inc.’s (TRNS) Stock Is Down 6.61%
As of Tuesday, May 19, Transcat, Inc.’s TRNS share price has dipped by 6.61%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Transcat, Inc.’s (TRNS) Stock Is Down 11.20%
As of Tuesday, May 19, Transcat, Inc.’s TRNS share price has dipped by 11.20%, which has investors questioning if this is right time to buy.Tudor Pop
Financial Summary
| Share Statistics | TRNS | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $799.0 | $4,922.5 | 43% |
|
| Shares Out (Mil) | 9.4 | 37.8 | 20% |
|
| Institutional Ownership | 97.7% | 63.8% | 75% |
|
| Float (Mil) | 9.1 | 47.9 | 18% |
|
| Beta | 0.68 | 0.97 | 39% |
|
| Avg Daily Volume (000s) | 109 | 235 | 37% |
|
| Price Change (52-week) |
10.3% | 80.3% | 54% |
|
| Growth | TRNS | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 13.9% | 8.9% | 70% |
|
| Net Income (5yr) | (7.1%) | 11.1% | 31% |
|
| EPS (5yr) | (11.2%) | 11.8% | 20 |
|
| Dividends (5yr) | 0.0% | 2.8% | 0% |
|
| Cash Flow (5yr) | 105.9% | (13.7%) | 99% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 4 | 4 | 4 | |
| Current EPS | $0.378 | $1.760 | $2.143 | |
| Month Ago EPS | $0.378 | $1.760 | $2.143 | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 2 | 1 | 1 | |
| Three Months Ago EPS | $0.487 | $2.065 | $2.150 | |
| Year/Year Chg | 89.0% | 208.8% | 457.9% | |
| Financials | TRNS | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $332 | $3,347 | 37% |
|
| Net Income (TTM) (Mil) | $5 | $137 | 43% |
|
| EPS (TTM) | $0.576 | $1.400 | 55% |
|
| Operating Cash Flow (TTM) (Mil) | $35 | $302 | 45% |
|
| Net Cash Flow (TTM) (Mil) | $3 | $3 | 51% |
|
| Long-Term Debt (Q1) (Mil) | $129 | $640 | 46% |
|
| Enterprise Value (Q1) (Mil) | $918 | $6,212 | 40% |
|
| Valuation | TRNS | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.65 | 2.65 | 61% |
|
| P/E | 149.8 | 25.8 | 96% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.4 | na |
|
| Ratios | TRNS | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 32.6% | 27.5% | 39% |
|
| Net Margin | 1.6% | 4.0% | 37% |
|
| ROA | 1.2% | 4.5% | 49% |
|
| ROE | 1.8% | 12.2% | 38% |
|
| Liabilities to Assets | 37.4% | 57.0% | 28% |
|
| F-Score | 5 | 5 | 51% |
|
Passing Stock Screens
As of 7/31/2026, from a list of 60 stock screening strategies,
FACTOR STRATEGY
Dual Cash Flow Screen
Factors: Quality, Growth
An analysis that can provide advance notice that a company may be facing financial trouble, though earnings and sales appear strong.
| Performance Since Inception: | 11.4% |
| +/- S&P 500: | +3.9 |
